FIRST HORIZON PHA, (FHRX) Stock Research Free Stock Rating

Company Profile

First Horizon Pharmaceutical Corporation (FHPC), a specialty pharmaceutical company, engages in the marketing and sale of prescription products for the treatment of cardiovascular, obstetrical and gynecological, and pediatric and gastroenterological conditions and disorders. The company’s products include Sular, an antihypertensive prescription medication; Nitrolingual spray for acute relief or prevention of chest pain associated with angina pectoris that results from heart disease for curing acute angina; Prenate Elite prescription prenatal vitamin products; Tanafed DP and Tanafed DMX for curing allergy and cold; Robinul and Robinul Forte for adjunctive therapy for peptic ulcer; and Ponstel for the relief of mild to moderate pain for patients of 14 years of age and older from dysmenorrheal, which is pain associated with menstruation. Its other products include Furadantin for the treatment of urinary tract infections in children; Cognex for the treatment of mild to moderate dementia associated with Alzheimer's disease; Zoto-HC ear drops for the treatment of swimmer's ear infections; and Zebutal capsules for the treatment of tension headaches. FHPC sells its products to pharmaceutical wholesalers, chain drug stores, and other retail merchandisers, as well as directly to pharmacies. The company is based in Alpharetta, Georgia.

Latest Headlines